The purpose of Agilent Labs is to power the growth of Agilent Technologies through breakthrough science and technology. To complement our partners in Agilent's product line R&D, we look beyond the evolution of current products and platforms to create the technologies and applications that will underlie tomorrow's breakthroughs enabling Agilent customers to answer new questions at the leading edge of life science, diagnostics and the applied markets. Our horizon is broad, encompassing synergies across Agilent and seeding new businesses to create competitive differentiation and compelling value for current and future customers and shareholders.

To accomplish these goals we attract and retain top technical talent, collaborate extensively with global research leaders in academia, government and industry, and promote a culture of innovation and teamwork across our highly multi-disciplinary staff of life scientists, physical scientists and engineers. The majority of our research is located in the United States in Santa Clara, California, with additional locations in Europe and Asia.

Eppendorf contributes to improving human living conditions.

Building on a foundation of collective experience, history and knowledge, we are committed to the future. We place our customers at the center of our activities. By being innovative, sincere, reliable and efficient, we offer our customers positive experiences and a sense of confidence. We take on responsibility and show courage.

Our premium products, systems and services enable, simplify and improve research and routine work in every laboratory around the world. They impress and inspire through innovation, quality, performance, ergonomics, value, smart solutions and design.

We continually invest in innovating our products, services and business solutions, also by engaging with partners and customers in strong networks, focused on applications in the fields of sample, cell and liquid handling. We stand by our customers.

We are committed to professionalism, flexibility and individuality in partnerships.  We all are Eppendorf – shaping the ongoing success story together!

Illumina is a leading developer, manufacturer, and marketer of life science tools and integrated systems for large-scale analysis of genetic variation and function. These systems are enabling studies that were not even imaginable just a few years ago, and moving us closer to the realization of personalized medicine. With rapid advances in technology taking place, it is mission-critical to offer solutions that are not only innovative, but flexible, and scalable, with industry-leading support and service.  We strive to meet this challenge by placing a high value on collaborative interactions, rapid delivery of solutions, and meeting the needs of our customers.

NanoString Technologies provides life science tools for translational research and molecular diagnostic products. The company's nCounter Analysis System has been employed in life sciences research since it was first introduced in 2008 and has been cited in more than 1,200 peer-reviewed publications. The nCounter Analysis System offers a cost-effective way to easily profile the expression of hundreds of genes, pro-teins, miRNAs, or copy number variations, simultaneously with high sensitivity and precision, facilitating a wide variety of basic research and translational medicine applications, including biomarker discovery and validation. The company's technology is also being used in diagnostics. The Prosigna® Breast Cancer Prognostic Gene Signature Assay together with the nCounter Dx Analysis System is FDA 510(k) cleared for use as a prognostic indicator for distant recurrence of breast cancer. In addition, the company is collabo-rating with multiple biopharmaceutical companies in the development of companion diagnostic tests for various cancer therapies, helping to realize the promise of precision oncology.

A supplier-of-choice for scientists across the globe, NEB offers the largest selection of recombinant and native enzymes for genomic research. While restriction enzymes remain part of our core product portfolio, our ever-expanding catalog also includes products related to PCR, gene expression, sample preparation for next generation sequencing, synthetic biology, glycobiology, epigenetics and RNA analysis. Additionally, NEB is focused on strengthening alliances that enable new technologies to reach key market sectors, including molecular diagnostics development.

Norgen Biotek provides researchers with innovative kits for Sample Collection/Preservation [cf-DNA from Blood/Plasma/Serum, Urine, Saliva, Molecular Diagnostics (MDx), and microRNA/RNA/DNA/Protein Purification. Our kits feature exceptional quality, ease-of-use and sensitivity. Norgen Biotek provides rsearchers worldwide with the tools to address any sample preservation and preparation challenge.

Thermo Fisher Scientific empowers researchers and clinicians with complete solutions to enable results. Translational researchers require a partner who understands the flexibility of exploratory research, orthogonal validation and pre-clinical implementation. Our Applied Biosystems branded sanger sequencer, real-time PCR and microarray solutions paired with Ion Torrent next generation sequencing applications meet the needs for the future of precision medicine. The Oncomine Dx Target Test is the first targeted next-generation sequencing (NGS) in vitro diagnostic test for non-small cell lung cancer (NSCLC), simultaneously delivering multiple biomarker results for multiple targeted therapies from one sample within 4 days.

10x Genomics is building tools for scientific discovery that reveal and address the true complexities of biology and disease. Through a combination of novel microfluidics, chemistry and bioinformatics, our award-winning Chromium System is enabling researchers around the world to more fully understand the fundamentals of biology at unprecedented resolution and scale.